RA Capital Management Q2 2022 holdings

$3.75 Billion is the total value of RA Capital Management's 88 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 37.5% .

 Value Shares↓ Weighting
ASND  ASCENDIS PHARMA A/Ssponsored adr$703,512
-20.8%
7,567,9000.0%18.76%
-3.2%
BIIB  BIOGEN INC$148,269
-3.2%
727,0240.0%3.95%
+18.3%
 CYTEK BIOSCIENCES INC$143,578
-0.5%
13,381,0540.0%3.83%
+21.6%
AVTE  AEROVATE THERAPEUTICS INC$129,166
-14.7%
8,263,9820.0%3.44%
+4.2%
DAWN BuyDAY ONE BIOPHARMACEUTICALS I$126,027
+109.6%
7,040,622
+16.2%
3.36%
+156.1%
TVTX  TRAVERE THERAPEUTICS INC$119,283
-6.0%
4,922,9410.0%3.18%
+14.9%
JANX  JANUX THERAPEUTICS INC$105,869
-14.9%
8,670,6440.0%2.82%
+4.1%
PCVX  VAXCYTE INC$99,687
-9.9%
4,581,2030.0%2.66%
+10.1%
IMGN  IMMUNOGEN INC$97,837
-5.5%
21,741,4580.0%2.61%
+15.5%
NKTX BuyNKARTA INC$96,159
+50.8%
7,805,129
+39.2%
2.56%
+84.2%
BLU  BELLUS HEALTH INC NEW$94,528
+34.3%
10,230,2740.0%2.52%
+64.1%
ITOS  ITEOS THERAPEUTICS INC$90,996
-36.0%
4,417,2590.0%2.43%
-21.8%
VERU NewVERU INC$89,2707,900,000
+100.0%
2.38%
 DICE THERAPEUTICS INC$80,842
-18.9%
5,208,9110.0%2.16%
-0.9%
NewPEPGEN INC$80,7508,131,952
+100.0%
2.15%
FMTX  FORMA THERAPEUTICS HLDGS INC$62,090
-25.9%
9,011,6510.0%1.66%
-9.5%
ACRS BuyACLARIS THERAPEUTICS INC$61,403
+95.9%
4,398,453
+142.0%
1.64%
+139.3%
PNT  POINT BIOPHARMA GLOBAL INC$61,311
-14.6%
9,003,0180.0%1.64%
+4.4%
CLDX  CELLDEX THERAPEUTICS INC NEW$55,942
-20.8%
2,075,0000.0%1.49%
-3.2%
WVE BuyWAVE LIFE SCIENCES LTD$55,907
+259.5%
17,202,009
+121.2%
1.49%
+339.8%
VOR  VOR BIOPHARMA INC$55,271
-17.7%
11,120,9730.0%1.47%
+0.5%
KNTE  KINNATE BIOPHARMA INC$53,771
+12.0%
4,264,1440.0%1.43%
+36.8%
 TYRA BIOSCIENCES INC$51,741
-33.2%
7,236,4540.0%1.38%
-18.3%
GHRS BuyGH RESEARCH PLCordinary shares$48,886
-44.6%
4,898,373
+1.5%
1.30%
-32.3%
GERN  GERON CORP$46,696
+14.0%
30,126,2990.0%1.24%
+39.3%
NTRA  NATERA INC$46,437
-12.9%
1,310,2890.0%1.24%
+6.4%
ABOS  ACUMEN PHARMACEUTICALS INC$45,923
+20.2%
9,770,7730.0%1.22%
+46.8%
NSTG NewNANOSTRING TECHNOLOGIES$45,5233,584,478
+100.0%
1.21%
 RXSIGHT INC$42,983
+13.7%
3,052,7960.0%1.15%
+38.9%
ENTA SellENANTA PHARMACEUTICALS INC$42,389
-38.2%
896,724
-7.0%
1.13%
-24.6%
 ELIEM THERAPEUTICS INC$39,716
-64.0%
13,150,8490.0%1.06%
-56.0%
RLMD  RELMADA THERAPEUTICS INC$37,980
-29.6%
2,000,0000.0%1.01%
-14.0%
TIL BuyINSTIL BIO INC$35,439
-32.3%
7,670,793
+57.5%
0.94%
-17.3%
 ICOSAVAX INC$34,172
-18.6%
5,963,5650.0%0.91%
-0.5%
RNA  AVIDITY BIOSCIENCES INC$31,492
-21.3%
2,167,3910.0%0.84%
-3.8%
DSGN  DESIGN THERAPEUTICS INC$30,613
-13.3%
2,186,6360.0%0.82%
+5.8%
BuyAN2 THERAPEUTICS INC$29,050
-47.4%
3,748,389
+2.2%
0.78%
-35.7%
RCKT  ROCKET PHARMACEUTICALS INC$28,994
-13.2%
2,107,1490.0%0.77%
+6.0%
EYPT  EYEPOINT PHARMACEUTICALS INC$26,526
-35.2%
3,370,5060.0%0.71%
-20.9%
ETNB Buy89BIO INC$25,060
+33.9%
7,782,669
+56.7%
0.67%
+63.7%
STSA  SATSUMA PHARMACEUTICALS INC$24,485
+8.9%
5,914,2520.0%0.65%
+33.3%
PMVP  PMV PHARMACEUTICALS INC$24,371
-31.6%
1,710,2650.0%0.65%
-16.3%
VERA SellVERA THERAPEUTICS INCcl a$21,488
-53.5%
1,578,820
-19.7%
0.57%
-43.2%
VRNA  VERONA PHARMA PLCsponsored ads$21,369
-16.0%
5,100,0000.0%0.57%
+2.7%
RYTM  RHYTHM PHARMACEUTICALS INC$20,215
-64.0%
4,871,0670.0%0.54%
-56.0%
 TENAYA THERAPEUTICS INC$19,995
-52.2%
3,551,5080.0%0.53%
-41.6%
DYN  DYNE THERAPEUTICS INC$19,271
-28.7%
2,805,0450.0%0.51%
-12.9%
NewHILLEVAX INC$19,2371,760,019
+100.0%
0.51%
GH  GUARDANT HEALTH INC$19,217
-39.1%
476,3800.0%0.51%
-25.7%
 PARDES BIOSCIENCES INC$18,957
-57.5%
6,175,0380.0%0.50%
-48.1%
HOWL  WEREWOLF THERAPEUTICS INC$17,554
-7.0%
4,291,8810.0%0.47%
+13.6%
 DA32 LIFE SCNCE$14,535
-0.3%
1,500,0000.0%0.39%
+22.0%
CNCE BuyCONCERT PHARMACEUTICALS INC$13,923
+36.2%
3,307,203
+9.0%
0.37%
+66.4%
MIST  MILESTONE PHARMACEUTICALS IN$13,816
-4.2%
2,246,5030.0%0.37%
+16.8%
ACHL  ACHILLES THERAPEUTICS PLCsponsored ads$12,637
-14.3%
5,014,6870.0%0.34%
+4.7%
BLSA  BCLS ACQUISITION CORP$12,375
+0.3%
1,250,0000.0%0.33%
+22.7%
OTIC  OTONOMY INC$11,648
-13.3%
5,600,0000.0%0.31%
+6.1%
SellLIANBIOsponsored ads$9,985
-64.8%
4,622,574
-39.6%
0.27%
-57.1%
FLACU  FRAZIER LIFESCIENCES ACQU CO$9,870
-1.2%
1,000,0000.0%0.26%
+20.6%
 ARYA SCIENCES ACQUISITN$9,720
+0.1%
1,000,0000.0%0.26%
+22.2%
RLAY  RELAY THERAPEUTICS INC$9,197
-44.0%
549,0550.0%0.24%
-31.8%
 IO BIOTECH INC$8,676
-11.9%
1,857,7550.0%0.23%
+7.4%
SLDB  SOLID BIOSCIENCES INC$7,614
-48.7%
12,367,8730.0%0.20%
-37.3%
FVAM  5 01 ACQUISITION CORP$7,425
+0.5%
750,0000.0%0.20%
+23.0%
SYBX SellSYNLOGIC INC$6,700
-58.1%
5,825,858
-12.6%
0.18%
-48.7%
BDTX  BLACK DIAMOND THERAPEUTICS I$6,371
-11.2%
2,589,9040.0%0.17%
+8.3%
IPSC SellCENTURY THERAPEUTICS INC$6,357
-44.8%
756,821
-17.2%
0.17%
-32.7%
HSAQ  HEALTH SCIENCES ACQ CORP 2$6,225
+0.5%
625,0000.0%0.17%
+23.0%
CNTB  CONNECT BIOPHARMA HLDGS LTDads$6,082
-71.2%
6,991,0030.0%0.16%
-64.9%
BMEA  BIOMEA FUSION INC$5,990
+168.6%
500,0000.0%0.16%
+226.5%
ATHA NewATHIRA PHARMA INC$5,7281,878,000
+100.0%
0.15%
SellXILIO THERAPEUTICS INC$4,817
-66.0%
1,649,711
-17.6%
0.13%
-58.6%
NewAADI BIOSCIENCE INC$4,719383,028
+100.0%
0.13%
FLDM NewSTANDARD BIOTOOLS INC$3,1801,987,589
+100.0%
0.08%
TERN NewTERNS PHARMACEUTICALS INC$3,1281,261,435
+100.0%
0.08%
ENTX  ENTERA BIO LTD$3,129
-53.7%
2,353,0000.0%0.08%
-43.5%
BCAB NewBIOATLA INC$2,9411,031,805
+100.0%
0.08%
SellASTRIA THERAPEUTICS INC$2,283
-73.0%
760,857
-39.7%
0.06%
-67.0%
SellPYXIS ONCOLOGY INC$2,269
-75.4%
953,393
-58.2%
0.06%
-70.1%
ADVM NewADVERUM BIOTECHNOLOGIES INC$2,0711,726,019
+100.0%
0.06%
LRMR SellLARIMAR THERAPEUTICS INC$2,022
-61.1%
1,031,482
-19.5%
0.05%
-52.2%
ORTX SellORCHARD THERAPEUTICS PLCads$1,776
-74.3%
3,040,885
-68.6%
0.05%
-68.9%
SNSE NewSENSEI BIOTHERAPEUTICS$1,642723,549
+100.0%
0.04%
CVRX  CVRX INC$1,653
+0.4%
275,0000.0%0.04%
+22.2%
OLMA SellOLEMA PHARMACEUTICALS INC$952
-55.7%
233,793
-53.7%
0.02%
-46.8%
BOLT NewBOLT BIOTHERAPEUTICS INC$918450,141
+100.0%
0.02%
AVRO NewAVROBIO INC$515559,600
+100.0%
0.01%
CLBS NewCALADRIUS BIOSCIENCES$399752,500
+100.0%
0.01%
CMPX ExitCOMPASS THERAPEUTICS INC$0-532,958
-100.0%
-0.02%
ExitTSCAN THERAPEUTICS INC$0-1,021,764
-100.0%
-0.06%
CGEM ExitCULLINAN ONCOLOGY INC$0-350,000
-100.0%
-0.08%
PHAS ExitPHASEBIO PHARMACEUTICALS INC$0-2,850,000
-100.0%
-0.08%
ExitCUE HEALTH INC$0-750,000
-100.0%
-0.11%
VERV ExitVERVE THERAPEUTICS INC$0-310,284
-100.0%
-0.16%
ALVR ExitALLOVIR INC$0-1,440,525
-100.0%
-0.21%
AKUS ExitAKOUOS INC$0-2,281,249
-100.0%
-0.24%
MORF ExitMORPHIC HLDG INC$0-278,874
-100.0%
-0.24%
CYT ExitCYTEIR THERAPEUTICS INC$0-3,350,506
-100.0%
-0.28%
GRPH ExitGRAPHITE BIO INC$0-2,698,369
-100.0%
-0.30%
KALA ExitKALA PHARMACEUTICALS INC$0-10,874,613
-100.0%
-0.33%
SCPH ExitSCPHARMACEUTICALS INC$0-2,658,583
-100.0%
-0.33%
KDNY ExitCHINOOK THERAPEUTICS INC$0-1,000,000
-100.0%
-0.36%
ExitTANGO THERAPEUTICS INC$0-2,250,000
-100.0%
-0.37%
EWTX ExitEDGEWISE THERAPEUTICS INC$0-2,613,623
-100.0%
-0.55%
KALV ExitKALVISTA PHARMACEUTICALS INC$0-1,930,322
-100.0%
-0.62%
CCXI ExitCHEMOCENTRYX INC$0-1,155,964
-100.0%
-0.63%
CNTA ExitCENTESSA PHARMACEUTICALS PLCsponsored ads$0-3,577,094
-100.0%
-0.70%
NVAX ExitNOVAVAX INC$0-692,794
-100.0%
-1.11%
MGNX ExitMACROGENICS INC$0-6,103,594
-100.0%
-1.17%
MRTX ExitMIRATI THERAPEUTICS INC$0-734,343
-100.0%
-1.32%

The following EDGAR filing(s) were analyzed to create this report:

The EDGAR filing(s) were signed by:

  • Rajeev Shah — Authorized Signatory

Compare quarterly holdings

Export RA Capital Management's holdings

EDGAR filings